Clinical Trial Update: Ziftomenib Maintenance Post Allo-HCT [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Ziftomenib as maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia (including NPM1-mutat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia in Remission
• Kmt2a-rearranged Acute Myeloid Leukemia
• Npm1-mutated Acute Myeloid Leukemia

Drugs mentioned

• Ziftomenib (ziftomenib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission | Phase 1 | Status: RECRUITING